UV-VIS Spectrophotometer

The FDA is seeking a UV-VIS Spectrophotometer to enhance the operational resilience of its Medical Products Labs by establishing system redundancy, expanding surge capacity during emergencies, and replacing aging infrastructure components. This procurement is critical to maintaining uninterrupted analytical capabilities essential for regulatory science and product safety assessments. The solicitation, identified as FDA-RFQ-134751, was posted on July 14, 2026, with proposals due by 5:00 PM EDT on July 27, 2026, and is classified as a combined solicitation with no set-aside provisions. The acquisition falls under NAICS code 334516 for laboratory analytical instrument manufacturing and is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The contract requires delivery to a place of performance in Detroit, Michigan, with a zip code of 48207, despite the issuing office being located in Rockville, Maryland. Roosevelt Walker of the FDA serves as the primary point of contact, reachable via email at roosevelt.walker@fda.hhs.gov. Interested respondents must submit proposals through the SAM.gov portal, with all technical and compliance requirements aligned to ensure seamless integration into existing laboratory workflows. The equipment must meet rigorous performance standards to support high-stakes testing and regulatory decision-making without disruption.